They found that the mRNA expression of bone morphogenetic protein 4 (BMP4) was positive in 81% of the lymphoblastoid cell lines from FOP patients and positive only in 8% of normal control cell lines (p < 0.01). The gene discussed is BMP4; the disease is fibrodysplasia ossificans progressiva.